SOMERSET, N.J., Nov. 12 /PRNewswire-FirstCall/ -- Ventiv Health, Inc. announced today an agreement with Watson Pharmaceuticals, whereby Ventiv’s Total Data Solutions (TDS) division will provide a variety of services to support Watson’s new Sales Force Automation platform and pharmaceutical sales software suite.
Ventiv’s TDS will provide Watson Pharmaceuticals’ mobile device configuration, rollout logistics and training. In addition, Ventiv will also supply help desk, hardware asset management, hosting, data warehousing, sample accountability, management reporting and other ongoing support services to complement Watson’s SFA implementation. The suite is being implemented for Watson’s entire field sales force. Field sales representatives and managers from Watson’s Specialty Products and Nephrology groups are currently being trained and deployed on the new system to manage professional and account data, plan routes, record call activity and replace paper processes.
“Through our Total Data Solutions division, we can more efficiently assess business needs and together with our clients, devise a solution to improve overall field effectiveness,” said Terrell Herring, President and COO, Ventiv Pharma Services. “Using this central, customized system, clients can instantly capture and receive territory data on a near real time basis.”
“By working with TDS, clients receive a complete portfolio of reports and services necessary to manage both the front and back ends of the sales force automation process,” said Jack Rubin, Ventiv’s newly appointed VP, Compliance Services.
For more information on Ventiv’s TDS division or service offerings, please contact Jack Rubin, Vice President, Compliance Services (800) 416-0555 or jrubin@ventiv.com.
About Ventiv Health
Ventiv Health, Inc. is a leading provider of late-stage clinical, sales, marketing and compliance solutions to the world’s largest pharmaceutical companies as well as to emerging and specialty pharmaceutical and biotech organizations. Ventiv’s clients include more than 75 pharmaceutical and biotech organizations, including virtually all of the top 20 global pharmaceutical companies.
The Ventiv delivery model is flexible and client-focused, enabling Ventiv to rapidly respond to changing client needs and market conditions across the full spectrum of late-stage clinical, sales, marketing and compliance services, with both integrated and independent programs. These include: Sales and Marketing Teams (Ventiv Sales and Marketing Teams(TM)), Clinical Staffing and Recruiting (Smith Hanley Corporation), Planning and Analytics (Health Products Research(R)), Sample Accountability/Patient Assistance Programs (The Franklin Group), Marketing Support (PROMOTECH), Recruitment (Ventiv Recruitment Services(TM)), Professional Development and Training (Ventiv Professional Development Group(TM)), Data Solutions (Total Data Solutions(TM)) and Clinical Support (The Therapeutics Institute(TM)). Ventiv is a multi- disciplinary company with a singular focus on providing excellence in customized solutions to meet clients’ late-stage clinical, sales, marketing and compliance objectives.
Ventiv’s approximately 4,000 employees support over 75 client organizations. For more information on Ventiv Health, visit http://www.ventiv.com/.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause Ventiv Health’s performance to differ materially. Such risks include, without limitation: changes in trends in the pharmaceutical industry or in pharmaceutical outsourcing; our ability to compete successfully with other services in the market; our ability to maintain large client contracts or to enter into new contracts; uncertainties related to future incentive payments; and, our ability to operate successfully in new lines of business. Readers of this press release are referred to documents filed from time to time by Ventiv Health Inc. with the Securities and Exchange Commission for further discussion of these and other factors.
Ventiv Health, Inc.
CONTACT: Investors, Corporate, John Emery, CFO of Ventiv Health, Inc.,+1-732-537-4804, investor@ventiv.com; or Media, Felicia Vonella of LazarPartners Ltd., +1-212-867-1762, fvonella@lazarpartners.com
Web site: http://www.ventiv.com/
